Found: 10
Select item for more details and to access through your institution.
Mostly natural sequencing-by-synthesis for scRNA-seq using Ultima sequencing.
- Published in:
- Nature Biotechnology, 2023, v. 41, n. 2, p. 204, doi. 10.1038/s41587-022-01452-6
- By:
- Publication type:
- Article
Author Correction: Massively parallel phenotyping of coding variants in cancer with Perturb-seq.
- Published in:
- 2022
- By:
- Publication type:
- Correction Notice
Massively parallel phenotyping of coding variants in cancer with Perturb-seq.
- Published in:
- Nature Biotechnology, 2022, v. 40, n. 6, p. 896, doi. 10.1038/s41587-021-01160-7
- By:
- Publication type:
- Article
Scalable, multimodal profiling of chromatin accessibility, gene expression and protein levels in single cells.
- Published in:
- Nature Biotechnology, 2021, v. 39, n. 10, p. 1246, doi. 10.1038/s41587-021-00927-2
- By:
- Publication type:
- Article
RNA-guided transcriptional silencing in vivo with S. aureus CRISPR-Cas9 repressors.
- Published in:
- Nature Communications, 2018, v. 9, n. 1, p. 1, doi. 10.1038/s41467-018-04048-4
- By:
- Publication type:
- Article
Epigenome editing by a CRISPR-Cas9-based acetyltransferase activates genes from promoters and enhancers.
- Published in:
- Nature Biotechnology, 2015, v. 33, n. 5, p. 510, doi. 10.1038/nbt.3199
- By:
- Publication type:
- Article
Correction of Dystrophin Expression in Cells From Duchenne Muscular Dystrophy Patients Through Genomic Excision of Exon 51 by Zinc Finger Nucleases.
- Published in:
- Molecular Therapy, 2015, v. 23, n. 3, p. 523, doi. 10.1038/mt.2014.234
- By:
- Publication type:
- Article
Multiplex CRISPR/Cas9-based genome editing for correction of dystrophin mutations that cause Duchenne muscular dystrophy.
- Published in:
- Nature Communications, 2015, v. 6, n. 2, p. 6244, doi. 10.1038/ncomms7244
- By:
- Publication type:
- Article
RNA-guided gene activation by CRISPR-Cas9-based transcription factors.
- Published in:
- Nature Methods, 2013, v. 10, n. 10, p. 973, doi. 10.1038/nmeth.2600
- By:
- Publication type:
- Article
Reading Frame Correction by Targeted Genome Editing Restores Dystrophin Expression in Cells From Duchenne Muscular Dystrophy Patients.
- Published in:
- Molecular Therapy, 2013, v. 21, n. 9, p. 1718, doi. 10.1038/mt.2013.111
- By:
- Publication type:
- Article